The Large Single-Specialty Group
When 50 Orthopedic Surgeons Are More Powerful Than a Hospital
Imagine a metropolitan area with one dominant orthopedic group: 45 surgeons across eight locations, running their own MRI centers, physical therapy clinics, and three ambulatory surgery centers. Every hospital in the region needs these surgeons for joint replacements, sports medicine, and spine surgery.
That group doesn’t need the hospital. The hospital needs them.
What It Is
A large single-specialty group is a physician-owned practice with dozens to hundreds of physicians all practicing within the same clinical specialty. Orthopedics, cardiology, gastroenterology, radiology, anesthesiology, emergency medicine — these are the specialties where large groups dominate.
They operate across multiple locations, often spanning a metro area or region. They achieve critical mass within their specialty, creating significant clinical and economic advantages.
Why It Exists
Concentrated volume in one specialty creates a competitive moat.
A 45-surgeon orthopedic group can negotiate reimbursement rates that a solo orthopedist never could. It can invest in subspecialty recruitment (a hand surgeon, a pediatric orthopedist, a spine specialist) that a small group can’t support. It can own its own ASCs and imaging centers, capturing the facility fees and ancillary revenue that would otherwise go to the hospital.
The economics are self-reinforcing: more surgeons attract more referrals, which fund more ancillary services, which generate more revenue per physician.
How It’s Organized
These groups are typically organized as physician-owned partnerships or professional corporations. Decision-making is centralized under an elected board or managing partner.
They negotiate directly with payers — often bypassing IPAs or CINs entirely. Their market position gives them leverage that smaller groups lack.
Their relationship with hospitals is symbiotic and often tense. Hospitals depend on them for surgical volume and call coverage. The group depends on hospitals for operating rooms and ICU backup. But when the group opens its own ASC, it’s directly competing with the hospital for cases.
The Tradeoffs
The upside is power. Significant payer negotiating leverage. Clinical standardization drives quality. Ancillary revenue capture (imaging, PT, ASCs). Ability to recruit subspecialists.
The downside is scrutiny. The FTC sued US Anesthesia Partners in 2023 for anticompetitive consolidation. Private equity has transformed many of these groups into margin-optimization machines. And market dominance can mean supracompetitive pricing — which draws regulatory attention.
The Bottom Line
Large single-specialty groups are among the most powerful entities in local healthcare markets. They prove that you don’t need to own a hospital to have leverage — you just need to be essential. But that power increasingly attracts antitrust scrutiny, especially when PE ownership amplifies the profit motive.